Media Coverage

Cancer is always a crisis. And lately, that crisis has been compounded by a shortage of two chemotherapy drugs, The New York Times reported. A shortfall of carboplatin and cisplatin is "forcing patients and their doctors to face even grimmer realities than those cancer typically presents." And there are few signs the shortage will end anytime soon. "Some companies that sell the medications are projecting that the shortage will last through the fall or later."

Several Republicans have already thrown their hat into the ring to garner the GOP nomination for the presidency. The tumultuous Republican primaries during the 2016 campaign were fueled by the large number of candidates and the “styles” that they employed, such as the inordinate use of social media, like Twitter, to promulgate their messages. The 2024 campaign leading up to Election Day could be even more chaotic, given the growth of generative artificial intelligence (AI) and how it may impact campaign information. 

The TSA's policy of evacuating airport terminals after security breaches could potentially create additional safety risks in the areas outside screening stations.

As one of the world’s leading automakers, General Motors (GM) has a history of developing innovative cars, including electric vehicles (EVs) since its founding in 1908. However, the company’s approach to EVs has been inconsistent. The company has repeatedly developed and abandoned EVs, switched to electric trucks, and invested in lithium mines. These actions suggest a lack of clear and consistent commitment to EV development. GM’s approach to EVs has continued to be characterized by short-term tactics rather than a clear long-term strategy.

Prolonged product shortages during the Covid pandemic were stressful. But they pale in comparison to the anxiety and uncertainty faced by many American cancer patients as the cancer drug shortage saga continues. Oncologists across the nation are being forced to ration life-saving drugs and alter treatment plans.